Of particular interest are putative markers among the coexpressed genes ILIR2 and ZNF218 that we validated in cohort 2 and they provided the best discrimination between primary and recurrent serous neoplasms in cohort 1. The gene discussed is TSHZ2; the disease is serous neoplasm.